Your browser doesn't support javascript.
loading
A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Cai, Jun; Tian, Xiaopeng; Ma, Shuyun; Zhong, Liye; Li, Wenyu; Wang, Liang; Guo, Linlang; Li, Zhihua; Wu, Yudan; Zhong, Guangzheng; Huang, Huiqiang; Xia, Zhongjun; Xia, Yi; Liu, Panpan; Su, Ning; Fang, Yu; Zhang, Yuchen; Cai, Qingqing.
Afiliação
  • Cai J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Tian X; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Ma S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Zhong L; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Li W; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Wang L; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Guo L; Department of Hematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, P. R. China.
  • Li Z; Lymphoma Division, Cancer Center of Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, P. R. China.
  • Wu Y; Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, P. R. China.
  • Zhong G; Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, P. R. China.
  • Huang H; Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P. R. China.
  • Xia Z; Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P. R. China.
  • Xia Y; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P. R. China.
  • Liu P; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Su N; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Fang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Zhang Y; Department of Hematology Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Cai Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Br J Cancer ; 125(3): 402-412, 2021 08.
Article em En | MEDLINE | ID: mdl-34012033
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B / Nomogramas / Rituximab Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B / Nomogramas / Rituximab Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Br J Cancer Ano de publicação: 2021 Tipo de documento: Article